Skip to main content

Advertisement

Table 4 Comparison of numbers of IOP-lowering medications according to occurrence of early hypertensive phase

From: Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant

  EHP (−) group (n = 15) EHP (+) group (n = 5) p-value
Month 1 0.8 ± 1.1 3.4 ± 0.5 0.001a
Month 2 1.0 ± 1.1 3.6 ± 0.5 0.001a
Month 3 1.2 ± 1.2 3.8 ± 0.4 0.000a
Month 6 1.3 ± 1.3 3.8 ± 0.4 0.002a
Year 1 1.3 ± 1.3 3.8 ± 0.4 0.005a
  1. aMann-Whitney U-test; IOP intraocular pressure, EHP early hypertensive phase